Skin sparing in intensity-modulated radiation therapy of nasopharyngeal carcinoma

被引:2
作者
Baba, Misba Hamid [1 ,2 ]
Singh, Benoy K. [1 ]
Wani, Shaq ul Qamar [3 ]
机构
[1] GLA Univ, Inst Appl Sci & Humanities, Dept Phys, Mathura, Uttar Pradesh, India
[2] Sherikashmir Inst Med Sci, Dept Radiol Phys & Bioengn, Srinagar, Jammu & Kashmir, India
[3] Sherikashmir Inst Med Sci, Dept Radiat Oncol, Srinagar, Jammu & Kashmir, India
关键词
Nasopharyngeal carcinoma; organ at risk; simultaneously instantaneous boost; skin sparing; RADIOTHERAPY; CHEMORADIOTHERAPY;
D O I
10.4103/jmp.jmp_27_22
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background and Purpose: Radiation therapy of nasopharyngeal carcinomas (NPCs) involves high doses to the target structures which are superficial to the skin surfaces. As a result, the skin toxicities involved are higher and sometimes worsens to such an extent that radiotherapy needs to be interrupted unplanned. This leads to a break in radiation therapy which overall affects the local control and cure rates. The aim of this study is to decrease the skin dose by contouring skin as an organ at risk (OAR) to include in inverse planning calculation. Materials and Methods: Seventy-three cases of nasopharyngeal cancers were planned for 60 Gy to intermediate-risk planning target volume (PTVIntermediate) and 70 Gy to high risk (PTVHigh), by three different modes of Intensity-modulated radiation therapy (IMRT)- namely conventional sequential intensity-modulated radiation therapy (S-IMRT PH-I and PH-II), Skin Spared sequential intensity-modulated radiation therapy (SS-IMRT PH-I and PH-II), and Skin Spared simultaneously instantaneous boost intensity-modulated radiation therapy (SS-SIB IMRT). The plans were compared by dose volume histograms and dose statistics to the PTV as well as to the OAR's. For PTV, mean dose (Dmean), maximum dose (Dmax), and minimum dose (Dmin) were compared to check the homogeneity index (HI) while sparing the skin. For other OAR's Dmean, Dmax and dose to to 1 cubic cm was used for comparison. The skin doses to various volumes from volume to receive 5 Gy (V5) to volume to receive 70 Gy (V70) were evaluated and compared between the three techniques. Statistical analysis was done using one away ANOVA on the data editor SPSS Version 26.0 (SPSS Inc., Chicago, Illinois, USA) to evaluate the results. Continuous variables were expressed as mean +/- standard deviation, and categorical variables were summarized as frequencies and percentages. Survival analysis was done by Kaplan-Meier Estimator. Results: When the skin was considered as an OAR, the skin volume to receive 5, 10, 15, 20, 30, 40, 50, 60, 70 Gy was reduced by 6.5%, 6.5%, 6%, 11.5%, 7%, 6%, 6%, 5%, 2%, respectively, by SS-IMRT PH-I and II and 2%, 4.05%, 4%, 7%, 5%, 3%, 6%, 5%, 1%, respectively, by SS-SIB IMRT when both the SS techniques were compared with S-IMRT PH-I and II. Volume of skin to receive 20 Gy showed maximum reduction in SS-IMRT PH-I and II. A one-way ANOVA was carried out to find the differences in the skin doses between the three techniques. The skin dose in the two SS techniques, i.e., SS-IMRT PH-I and PH-II and SS-SIB IMRT was found significantly lower than that of IMRT plans without skin as an OAR, i.e., S-IMRT PH-I and PH-II (P = 0.000). The PTV doses were well within the 95%-107% of the prescribed dose (HI) and there were no significant differences in the means of the prescribed dose between the simple and skin spared IMRT techniques. The other OARs doses were also evaluated and there were no significant differences between the means of the doses among the techniques. Conclusions: SS IMRT for NPC has demonstrated reduction in skin dose while using skin as an OAR in the optimization. Moreover, decreased skin dose can decrease the skin related toxicities provided there is no compromise on Target dose coverage and OAR dose. We recommend that skin should be contoured as an OAR for NPC, provided PTV is minimally 3-5 mm beneath skin surface, in order to have a better disease control with lesser toxicities and less unplanned treatment interruptions.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [21] Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer
    Marucci, Laura
    Marzi, Simona
    Sperduti, Isabella
    Giovinazzo, Giuseppe
    Pinnaro, Paola
    Benassi, Marcello
    Strigari, Lidia
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (03): : 328 - 335
  • [22] Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era
    Guo, Qiaojuan
    Lu, Tianzhu
    Lin, Shaojun
    Zong, Jingfeng
    Chen, Zhuhong
    Cui, Xiaofei
    Zhang, Yu
    Pan, Jianji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 241 - 247
  • [23] Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy
    Huang, Huixian
    Lu, Heming
    Feng, Guosheng
    Jiang, Hailan
    Chen, Jiaxin
    Cheng, Jinjian
    Pang, Qiang
    Lu, Zhiping
    Gu, Junzhao
    Peng, Luxing
    Deng, Shan
    Mo, Ying
    Wu, Danling
    Wei, Yinglin
    RADIATION ONCOLOGY, 2015, 10
  • [24] Intensity modulated radiation therapy in nasopharyngeal carcinoma
    Haberer-Guillerm, S.
    Touboul, E.
    Huguet, F.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2015, 132 (03) : 147 - 151
  • [25] Radiation caries in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy: A cross-sectional study
    Liang, Xue
    Zhang, Jingyang
    Peng, Guang
    Li, Jiyao
    Bai, Sen
    JOURNAL OF DENTAL SCIENCES, 2016, 11 (01) : 1 - 7
  • [26] Intensity-Modulated Radiation Therapy Without Concurrent Chemotherapy for Stage IIB Nasopharyngeal Cancer
    Tham, Ivan Weng Keong
    Lin, Shaojun
    Pan, Jianji
    Han, Lu
    Lu, Jiade J.
    Wee, Joseph
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 294 - 299
  • [27] Intensity-modulated radiation therapy for anal carcinoma
    Peiffert, D.
    Moreau-Claeys, M. -V.
    Tournier-Rangeard, L.
    Huger, S.
    Marchesi, V.
    CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 549 - 554
  • [28] A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy (IMRT)
    Kang, Min
    Zhou, Pingting
    Long, Jianxiong
    Li, Guisheng
    Yan, Haolin
    Feng, Guosheng
    Liu, Meilian
    Zhu, Jinxian
    Wang, Rensheng
    ONCOTARGET, 2017, 8 (55) : 94188 - 94196
  • [29] Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion
    Shufang Liao
    Yuan Xie
    Yi Feng
    Yuanyuan Zhou
    Yufei Pan
    Jinfang Fan
    Jinglin Mi
    Xiaoli Qin
    Dacheng Yao
    Wei Jiang
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 429 - 439
  • [30] Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
    Yin, Wen-Jing
    Chen, Dong-Ping
    Wang, Meng-Yao
    Zheng, Lu
    Dong, En-Lai
    Liu, Jin-Quan
    Qi, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (16)